Skip to main content
. 2015 Sep 2;41(1):45–57. doi: 10.1038/npp.2015.224

Figure 3.

Figure 3

Basolateral amygdala inactivation or intra-basolateral infusions of mifepristone reduces SEFL. (a) Experimental design for intra-amygdalar muscimol infusions. (b) Cannulae placement for amygdalar inactivation. (c) Freezing (mean+SEM) in the conditioning context on Day 3. **p<0.003 (one-way ANOVA, followed by planned contrasts). (d) Experimental design for mifepristone infusions. (e) Cannulae placement for mifepristone infusions. (f) Freezing (mean+SEM) in the conditioning context on Day 3. **p<0.001 (one-way ANOVA, followed by planned contrasts).